Prescription-only medicine named
High risk. CAP Code rule 12.12 bans advertising prescription-only medicines to the public. Naming the medicine, its brand or its active ingredient in an ad, a promoted post or a treatment page that works as an ad is a clear breach, even if a prescriber will assess every patient first.
